These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 16288016)

  • 1. The differential effects of mutant p53 alleles on advanced murine lung cancer.
    Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T
    Cancer Res; 2005 Nov; 65(22):10280-8. PubMed ID: 16288016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
    Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of lung cancer progression by bexarotene in mouse models.
    Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
    Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutations in the tumor suppressor gene p53.
    van Oijen MG; Slootweg PJ
    Clin Cancer Res; 2000 Jun; 6(6):2138-45. PubMed ID: 10873062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 in craf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch.
    Fedorov LM; Papadopoulos T; Tyrsin OY; Twardzik T; Götz R; Rapp UR
    Cancer Res; 2003 May; 63(9):2268-77. PubMed ID: 12727849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.
    Duan W; Ding H; Subler MA; Zhu WG; Zhang H; Stoner GD; Windle JJ; Otterson GA; Villalona-Calero MA
    Oncogene; 2002 Nov; 21(51):7831-8. PubMed ID: 12420220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
    Wang Y; Zhang Z; Lubet R; You M
    Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
    Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
    Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
    Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
    Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein.
    Morris GF; Hoyle GW; Athas GB; Lei WH; Xu J; Morris CB; Friedman M
    J La State Med Soc; 1998 Apr; 150(4):179-85. PubMed ID: 9610073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friend virus induced murine erythroleukaemia: the p53 locus.
    Johnson P; Benchimol S
    Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 transdominance but no gain of function in mouse brain tumor model.
    Hegi ME; Klein MA; Rüedi D; Chène P; Hamou MF; Aguzzi A
    Cancer Res; 2000 Jun; 60(11):3019-24. PubMed ID: 10850451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic mouse model for metastatic lung cancer with gender differences in survival.
    Zheng S; El-Naggar AK; Kim ES; Kurie JM; Lozano G
    Oncogene; 2007 Oct; 26(48):6896-904. PubMed ID: 17486075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
    Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
    Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
    Gurova KV; Rokhlin OW; Budanov AV; Burdelya LG; Chumakov PM; Cohen MB; Gudkov AV
    Cancer Res; 2003 Jun; 63(11):2905-12. PubMed ID: 12782597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
    Fu XY; Bin XN; Tan M
    Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.